drugset
drugset / Trial / NCT04906785

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

NCT04906785 ↗

Phase 1 Unknown 52 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

Timeline

Start
2021-06-04
Primary completion
2021-07-30
Completion
2021-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-385 Unknown — —
Subject D744 Unknown — —

Indications

cardiovascular disorder